Metastatic papillary thyroid carcinoma in pleural effusion: a case report and review of the literature.
Mohammed Ali AbutalibAnwar M ShamsShadi TamurEman A KhalifaGhaliah Obaid AlnefaieYousef M HawsawiPublished in: Journal of medical case reports (2023)
Papillary thyroid carcinoma seldom causes metastatic niches in the pleural space; this is a rare clinical presentation, nevertheless, a differential diagnosis of thyroid metastasis needs to be excluded. A definitive diagnosis of metastatic papillary thyroid carcinoma can be made using clinical presentation, cytologic examination, immunohistochemical investigation, and molecular testing. The most common mutation found in papillary thyroid carcinoma cases is the V600E mutation found in the BRAF gene, yet these patients have a relatively low probability of cancer recurrence. Patients with papillary thyroid carcinoma who have the BRAF mutation frequently experience metastases and relapses of the disease after the cancer has progressed aggressively. To help with therapy planning and the introduction of BRAF inhibitors, genetic testing for BRAF mutation may therefore prove to be a useful tool, especially in cases of aggressive subtypes of TC.
Keyphrases
- lymph node metastasis
- papillary thyroid
- squamous cell carcinoma
- lymph node
- small cell lung cancer
- metastatic colorectal cancer
- wild type
- end stage renal disease
- newly diagnosed
- ejection fraction
- squamous cell
- locally advanced
- prognostic factors
- stem cells
- genome wide
- single molecule
- young adults
- gene expression
- copy number
- fine needle aspiration